| |
|
|
| |
|
|
| |
HUM-MOLGEN
-> Events
-> Courses and Workshops |
|
|
| |
| |
| |
April 01, 2010 |
|
|
| |
|
|
| |
|
|
|
SAS Radisson Hotel Boulogne , Boulogne-Billancourt (Paris), France
Sep 13 2010 8:00AM - Sep 14 2010 5:00PM
The 17th edition of this annual training course, considered by many experts as one of the pillars of medical training in pharmacovigilance, focuses on how to use the medical knowledge in the diagnosis and management of selected Adverse Drug Reactions (ADRs).
A medical approach is needed for the identification, labelling and understanding of ADR mechanisms. It can also improve the evaluation of the probability that a medicinal product may have played a role in the occurrence of an adverse event. This is particularly useful for the first 2 or 3 cases of serious reactions occurring during clinical trials when important decisions must be taken regarding a new drug under development.
The medical approach presented during this training course is mainly based on the conclusions of international or national consensus
meetings on adverse drug reactions.
Highlights: Medical Approach in Clinical Safety Drug-Associated Affective Symptoms Drug-Induced Blood Disorders Drug-Induced Liver Disorders Drugs in Pregnancy Drug-Induced Renal Disorders Drug-Induced Skin Reactions Drug-Induced QT Prolongation
Event Code:
10531
|
|
|
|
|
|
|
|
Organized by:
|
|
DIA Europe |
|
|
Invited Speakers:
|
|
call contact
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
call contact
|
|
|
|
|
|
|
|
Registration:
|
|
DIA Europe TEL.: +41 61 225 51 51FAX: +41 61 225 51 52
|
|
|
E-mail:
|
|
DIAEUROPE@DIAEUROPE.ORG
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp,
Frank S.
Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved.
Liability, Copyright and Imprint. |
|